← FDA Drug Approvals (Drugs@FDA)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2024-01-02
Drug application
- FDA Application #
ANDA211148- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
- Generic name
- Emtricitabine, Tenofovir Alafenamide
- Active ingredients
- EMTRICITABINE, TENOFOVIR ALAFENAMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN LABS LTD
- First approval
- 2024-01-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown